Skip to main content
. 2021 Nov 25;9:757184. doi: 10.3389/fcell.2021.757184

FIGURE 2.

FIGURE 2

Kaplan-Meier survival analysis of ATG5 compared with different clinical parameters. By comparison, high expression of ATG5 in cervical patients with most different (A) T stage (B) N stage (C) M stage (D) FIGO stage (E) pathological grade, and (F) Ages at diagnosis showed shorter median OS time; Cervical patients with (G) Cervical squamous cell carcinoma, and (H) Cervical adenocarcinoma had shorter OS in ATG5 overexpression group.